Randy Fowler
Analyst · Keith Stanley from Wolfe Research
Okay. Thank you, Jim. Good morning, everyone. Starting with first quarter income statement items. Net income attributable to common unitholders for the first quarter of 2024 increased 5% to $1.5 billion or $0.66 per common unit on a fully diluted basis compared to $1.4 billion or $0.63 per common unit for the first quarter of 2023. Turning to cash flow. Adjusted cash flow from operations, which is cash flow from operating activities before changes in working capital increased 6% to $2.1 billion for the first quarter of 2024 compared to $2 billion for the first quarter of last year. We declared a distribution of $0.515 per common unit for the first quarter of 2024. As Jim mentioned, this is a 5.1% increase over the distribution declared with regard to the first quarter of 2023. The distribution will be paid May 14 to common unitholders of record as of the close of business today. In the first quarter, the partnership purchased approximately 1.4 million common units of the open market for $40 million, total purchases for the 12 months ending March 31 were $211 million or approximately 8 million enterprise common units, bringing total purchases under our buyback program to approximately $960 million. In addition to buybacks, our distribution reinvestment plan and employee unit purchase plan purchased a combined 6.5 million common units on the open market for $172 million during the last 12 months, including 1.6 million common units on the open market for $43 million during the first quarter of 2024. For the 12 months ended March 31, 2024, Enterprise paid out approximately $4.4 billion in distributions to limited partners combined with the $211 million of common unit repurchases across the same time period. Enterprise's payout ratio of adjusted cash flow from operations was 56% for that 12-month period. Total capital investments in the first quarter were $1.1 billion, which included $875 million for growth capital projects and $180 million of sustaining CapEx. We expect growth capital expenditures for 2024 and 2025 to be in the range of $3.25 billion to $3.75 billion. We continue to estimate 2024 sustaining capital expenditures to be approximately $550 million, which includes planned turnarounds at both of our PDH plants our iBDH facility, and high-purity isobutylene facility. As previously mentioned, these scheduled turnarounds typically occur every 3 to 4 years. At this time, we expect the PDH turnaround to be completed in May 2024. We plan to begin addressing the issues on the fourth reactor within PDH 2 in June. Our total debt principal outstanding was approximately $29.7 billion as of March 31, 2024. Assuming the final maturity date for our hybrids, the weighted average life of our debt portfolio is approximately 19 years. Our weighted average cost of debt is 4.7%. At March 31, approximately 98% of our debt was fixed rate. Our consolidated liquidity was approximately $4.5 billion at the end of the first quarter, including availability under our credit facilities and unrestricted cash on hand. Our adjusted EBITDA for the first quarter was $2.5 billion and $9.5 billion for the trailing 12 months. As of March 31, 2024, our consolidated leverage ratio was 3.0x on a net basis after adjusting debt for the partial equity treatment of our hybrid debt and reducing the debt outstanding by the partnership's unrestricted cash on hand. As a reminder, our leverage target remains 3.0x, plus or minus 0.25x. And with that, Libby, I think we can open it up for questions.